ΩΎϘόϟ΍ΔΤλϰϔθΘδϣ ωή˰˰˰ϔϟ΍Ϣ˰˰˰γ΍ Γέ΍Ωϻ΍βϠΠϣβϴ΋έ

ϝ΍ϰϧϮϴδΑϰϧϮϴδΑ˯ϻϭΩ ωή˰˰ϔϟ΍ή˰ϳΪ˰ϣ ϞϣΎϛϪϨϣΆϣΩ΍

ϰϠϘϨϟ΍ΰϳΰόϟ΍ΪΒϋΩ΍ ϩΪΣϮϟ΍ή˰ϳΪ˰ϣ
ϰδϴδϟ΍ϼϋΩ΍ ϩΪΣϮϟ΍ΐϴΒρ ϞϣΎόϤϟ΍ήϳΪϣ
Ϣϴϫ΍ήΑ΍ΕΎϳ΍Ω΍ ϲϨϴΑήθϟ΍ΪϨϫΩ΍

PATIENT NAME Registered 23-02-2024 15:23:04 Collected 23-02-2024 15:24:18

ΪϤΤϣϲϨϬϣϲϨϬϣ˯ϼΠϧ Authenticated 23-02-2024 17:05:54 Printed 24-02-2024 17:25:55
Visit Number Age Gender Referred By Client ID
75324502146 49 Year Female Prof : - 1320

Test Name Result Unit Reference Range Previous Result

Diabetic Profile

Haemoglobin A1C 5.8 % Normal: Less than 5.7

Prediabetes: 5.7 - 6.4
Diabetes: More than 6.4

Liver Function Tests

Total Bilirubin 0 .48 mg/dl 0 - 1.2

Direct Bilirubin 0 .14 mg/dL 0 - 0.3

Indirect Bilirubin 0 .34 mg/dL 0 - 0.9

SGPT (ALT) 25.2 U/L 0 - 33

SGOT (AST) 21.9 U/L 0 - 32

Kidney Function Tests

Serum Creatinine 0.410 mg/dL 0.5 - 1.1

Serum Urea 16.56 mg/dL 13 - 43

Thyroid Function Tests

T3-Total 175 ng/dL 60 - 181

Assay Method: CLIA/ECLIA

T4-Total 11.0 ug/dL 3.2 - 12.6

Assay Method: CLIA/ECLIA

TSH 2 .72 uIU/mL 0.55 - 4.78

Assay Method: CLIA/ECLIA

Many factors affect TSH levels including circadian rhythm (peak around midnight and a low in the afternoon), diet (High-Fiber Diet or
Goitrogenic Foods), thyroid therapy, autoimmune thyroiditis and stress. Such factors act as Non-thyroidal illness affecting TSH levels
without any effect on thyroid gland.

Dr.ABD El-Aziz El-Nokaly

Professor of Medical Bio-Chemistry,
Faculty of medicine, EL Azhar University 1-2
 ΩΎϘόϟ΍ΔΤλϰϔθΘδϣ ωή˰˰˰ϔϟ΍Ϣ˰˰˰γ΍ Γέ΍Ωϻ΍βϠΠϣβϴ΋έ
ϝ΍ϰϧϮϴδΑϰϧϮϴδΑ˯ϻϭΩ ωή˰˰ϔϟ΍ή˰ϳΪ˰ϣ ϞϣΎϛϪϨϣΆϣΩ΍
ϰϠϘϨϟ΍ΰϳΰόϟ΍ΪΒϋΩ΍ ϩΪΣϮϟ΍ή˰ϳΪ˰ϣ
ϰδϴδϟ΍ϼϋΩ΍ ϩΪΣϮϟ΍ΐϴΒρ ϞϣΎόϤϟ΍ήϳΪϣ
Ϣϴϫ΍ήΑ΍ΕΎϳ΍Ω΍ ϲϨϴΑήθϟ΍ΪϨϫΩ΍

PATIENT NAME Registered 23-02-2024 15:23:04 Collected 23-02-2024 15:24:18

ΪϤΤϣϲϨϬϣϲϨϬϣ˯ϼΠϧ Authenticated 23-02-2024 17:05:54 Printed 24-02-2024 17:25:55
Visit Number Age Gender Referred By Client ID
75324502146 49 Year Female Prof : - 1320

Test Name Result Unit Reference Range Previous Result

Lipid Profile
Serum Total Cholesterol 211 .0 mg/dL Normal : Up to 200
Borderline Risk : 200-240
High Risk : > 240

Serum Triglycerides 158 .0 mg/dL 0 - 150

HDL Cholesterol 50. mg/dL Low risk factor for CHD : >= 60
High risk factor for CHD : < 40

LDL Cholesterol 129 .0 mg/dL 0 - 100

VLDL Cholesterol 32 .0 mg/dL 0 - 30

Non-HDL cholesterol 161 .0 mg/dL 0 - 130

HDL Risk Factor 4.2 Mild risk : 4.4

Moderate risk : 7.1
High risk : 11.0

According to ESC/EAS and NCEP Guidelines, LDL Target Goal:

Very High CHD risk : < 55 mg/dL
High CHD risk : < 70 mg/dL
Moderate CHD risk : < 100 mg/dL
Low CHD risk : < 116 mg/dL

Dr.ABD El-Aziz El-Nokaly

Professor of Medical Bio-Chemistry,
Faculty of medicine, EL Azhar University 2-2
 ΩΎϘόϟ΍ΔΤλϰϔθΘδϣ ωή˰˰˰ϔϟ΍Ϣ˰˰˰γ΍ Γέ΍Ωϻ΍βϠΠϣβϴ΋έ
ϝ΍ϰϧϮϴδΑϰϧϮϴδΑ˯ϻϭΩ ωή˰˰ϔϟ΍ή˰ϳΪ˰ϣ ϞϣΎϛϪϨϣΆϣΩ΍
ϪΒϴηΔϟΎϫΩ΍ ϩΪΣϮϟ΍ή˰ϳΪ˰ϣ
βϴϤΧ˯ΎϋΩΩ ϩΪΣϮϟ΍ΐϴΒρ ϞϣΎόϤϟ΍ήϳΪϣ
ϥΎπϣέϦΗΎϓΩ ϲϨϴΑήθϟ΍ΪϨϫΩ΍

PATIENT NAME Registered 23-02-2024 15:23:04 Collected 23-02-2024 15:24:17

ΪϤΤϣϲϨϬϣϲϨϬϣ˯ϼΠϧ Authenticated 23-02-2024 16:45:39 Printed 24-02-2024 17:25:57
Visit Number Age Gender Referred By Client ID
75324502146 49 Year Female Prof : - 1320

Coagulation
Test Name Result Unit Reference Range

Prothrombin Time
Prothrombin Time 11.4 sec 11 - 18
Control (MPPT): 13.0 sec
Prothrombin Concentration 117.0 % 70 - 130
INR 0 .880 0.85 - 1.15

Sample Type: Citrated Plasma

Method: Optical Clot-Based

INR values should only be used when evaluating patients on oral anticoagulant therapy.
Target Therapeutic Values:
INR 2.0 - 3.0 : Prophylaxis of venous thromboembolism, treatment of venous thrombosis (following heparin therapy), prevention of
systemic embolism (atrial fibrillation, valvular heart disease, bioprosthetic heart valves, acute myocardial infarction).
INR 2.5 - 3.5 : Mechanical prosthetic heart valves, recurrent systemic embolism.

Activated Partial Thromboplastin 31.2 sec 23 - 40

Time (aPTT)
Sample type: Citrated Plasma
Method: Optical Clot-Based

Dr.Hala Sheba
Professor of clinical pathology,
Faculty of medicine, Cairo university 1-1